Novel pattern recognition methods for classification and detection in remote sensing and power generation applications

Novel pattern recognition methods for classification and detection in remote sensing and power generation application

experimental evaluation of artificial defects using smart thermography

Abstract SMArt termography is an innovative and promising technique that could be useful for the detection of damages of large components subjected to in-service loads, like wind blade. This technique requires building traditional carbon or glass fiber reinforced composite laminates adding a regular net of Shape Memory Alloy (SMA) wires in the matrix. These wires confer to the composite material additional features. In particular, the electro-thermal properties of SMA could be used as an internal heat source to be used for the control of the component using the traditional numerical technique used to elaborate the raw thermal data. Despite of other thermography techniques, SMArt thermography is characterized by a quite reduced amount of heating power, which produces a limited increasing of the temperature of the component subjected to control. On the other hand, the numerical elaboration of thermal data acquired from IR camera is more sensitive and require a deeper comprehension of the phenomena. In this work, a GFRP composite panel containing several artificial defects has been studied both from a numerical and experimental point of view, in order to determine the sensitivity of the technique, the limit of applicability and practical indications about the reliability of the technique

Numerical and experimental validation of SMArt thermography for the inspection of wind blade composite laminate

none3noAn innovative active thermography technique is proposed for the inspection of typical wind blade material. The proposed technique is based on the use of a multifunctional material obtained adding a grid of Shape Memory Alloy wires, which would serve also as a protection against lightning, to a traditional glass fibre composite panel. This technique, called SMArt thermography, which exploits the SMA wires as internal heat sources, has been compared to a traditional pulsed thermography in the case of a representative panel of unidirectional glass fibre and epoxy matrix with embedded SMA wires and artificial defects. The experimental results of the two techniques are reported and compared to the result of a numerical FEM transient model, in order to establish the reliability and the detectability limit of the proposed technique. The FEM model has been proven to be a useful tool for the definition of the multifunctional material at a design stage.openMarta De Giorgi; Riccardo Nobile; Andrea SaponaroDE GIORGI, Marta; Nobile, Riccardo; Saponaro, Andre

Experimental evaluation of artificial defects using SMArt thermography

SMArt termography is an innovative and promising technique that could be useful for the detection of damages of large components subjected to in-service loads, like wind blade. This technique requires building traditional carbon or glass fiber reinforced composite laminates adding a regular net of Shape Memory Alloy (SMA) wires in the matrix. These wires confer to the composite material additional features. In particular, the electro-thermal properties of SMA could be used as an internal heat source to be used for the control of the component using the traditional numerical technique used to elaborate the raw thermal data. Despite of other thermography techniques, SMArt thermography is characterized by a quite reduced amount of heating power, which produces a limited increasing of the temperature of the component subjected to control. On the other hand, the numerical elaboration of thermal data acquired from IR camera is more sensitive and require a deeper comprehension of the phenomena. In this work, a GFRP composite panel containing several artificial defects has been studied both from a numerical and experimental point of view, in order to determine the sensitivity of the technique, the limit of applicability and practical indications about the reliability of the technique

Real-world outcomes of concomitant antidepressant and statin use in primary care patients with depression: a population-based cohort study

Background Antidepressants are licensed for use in depressive disorders, but non-response and poor adherence to treatment affect a considerable number of patients. Pre-clinical and clinical evidence suggest that statins can augment the effects of antidepressants. However, the acceptability and tolerability of combining statins with antidepressants are unclear, and their add-on efficacy has only been shown in small, short-term clinical trials. Observational data can provide complementary information about treatment effects on larger samples over longer follow-ups. In this study, we therefore assessed the real-world acceptability, tolerability, and efficacy of concomitant antidepressant and statin treatment in depression. Methods We conducted a population-based cohort study investigating QResearch primary care research database, which comprises the anonymised electronic healthcare records of 35 + million patients over 1574 English general practices. Patients aged 18–100 years, registered between January 1998 and August 2020, diagnosed with a new episode of depression, and commencing an antidepressant were included. Using a between-subject design, we identified two study groups: antidepressant + statin versus antidepressant-only prescriptions. Outcomes of interest included the following: antidepressant treatment discontinuations due to any cause (acceptability) and due to any adverse event (tolerability) and effects on depressive symptoms (efficacy) measured as response, remission, and change in depression score on the Patient Health Questionnaire-9. All outcomes were assessed at 2, 6, and 12 months using multivariable regression analyses, adjusted for relevant confounders, to calculate adjusted odds ratios (aORs) or mean differences (aMDs) with 99% confidence intervals (99% CIs). Results Compared to antidepressant-only (N 626,335), antidepressant + statin (N 46,482) was associated with higher antidepressant treatment acceptability (aOR2months 0.88, 99% CI 0.85 to 0.91; aOR6months 0.81, 99% CI 0.79 to 0.84; aOR12months 0.78, 99% CI 0.75 to 0.81) and tolerability (aOR2months 0.92, 99% CI 0.87 to 0.98; aOR6months 0.94, 99% CI 0.89 to 0.99, though not long term aOR12 months 1.02, 99% CI 0.97 to 1.06). Efficacy did not differ between groups (range aOR2-12 months 1.00 and 1.02 for response and remission, range aOR2-12 months − 0.01 and − 0.02 for change in depression score). Conclusions On real-world data, there is a positive correlation between antidepressant treatment adherence and statin use, partly explained by fewer dropouts due to adverse events. The main limitation of our study is its observational design, which restricts the potential to make causal inferences

Identification of murine phosphodiesterase 5A isoforms and their functional characterization in HL-1 cardiac cell line

Phosphodiesterase 5A (PDE5A) specifically degrades the ubiquitous second messenger cGMP and experimental and clinical data highlight its important role in cardiac diseases. To address PDE5A role in cardiac physiology, three splice variants of the PDE5A were cloned for the first time from mouse cDNA library (mPde5a1, mPde5a2 and mPde5a3). The predicted amino acidic sequences of the three murine isoforms are different in the N-terminal regulatory domain. mPDE5A isoforms were transfected in HEK293T cells and they showed high affinity for cGMP and similar sensitivity to sildenafil inhibition. RT-PCR analysis showed that mPde5a1, mPde5a2 and mPde5a3 had differential tissue distribution. In the adult heart, mPde5a1 and mPde5a2 were expressed at different levels whereas mPde5a3 was undetectable. Overexpression of mPDE5As induced an increase of HL-1 number cells which progress into cell cycle. mPDE5A1 and mPDE5A3 overexpression increased the number of polyploid and binucleated cells, mPDE5A3 widened HL-1 areas and modulated hypertrophic markers more efficiently respect to the other mPDE5A isoforms. Moreover, mPDE5A isoforms had differential subcellular localization: mPDE5A1 was mainly localized in the cytoplasm, mPDE5A2 and mPDE5A3 were also nuclear localized. These results demonstrate for the first time the existence of three PDE5A isoforms in mouse and highlight their potential role in the induction of hypertrophy. This article is protected by copyright. All rights reserved

Sub-50-nm conjugated polymer dots by nanoprinting.

n/

Mortality and adverse events associated with statin use in primary care patients with depression: a real-world, population-based cohort study

Background: New National Institute for Health and Care Excellence (NICE) guidance endorses the prescription of statins in larger population groups for the prevention of cardiovascular and cerebrovascular morbidity and mortality, especially in people with severe mental illness. However, the evidence base for their safety and risk/benefit balance in depression is not established. Objectives: This study aims to assess the real-world mortality and adverse events of statins in depressive disorders. Methods: Population-based, nationwide (England), between-subject, cohort study. We used electronic health records (QResearch database) of people aged 18–100 years with first-episode depression, registered with English primary care practices over January 1998–August 2020 for 12(+) months, divided into statin users versus non-users. Primary safety outcomes included all-cause mortality and any adverse event measured at 2, 6 and 12 months. Multivariable logistic regression was employed to control for several potential confounders and calculate adjusted ORs (aORs) with 99% CIs. Findings: From over 1 050 105 patients with depression (42.64% males, mean age 43.23±18.32 years), 21 384 (2.04%) died, while 707 111 (67.34%) experienced at least one adverse event during the 12-month follow-up. Statin use was associated with lower mortality over 12 months (range aOR2–12months 0.66–0.67, range 99% CI 0.60 to 0.73) and with lower adverse events over 6 months (range aOR2–6months 0.90–0.96, range 99% CI 0.91 to 0.99), but not at 1 year (aOR12months 0.99, 99% CI 0.96 to 1.03). No association with any other individual outcome measure (ie, any other neuropsychiatric symptoms) was identified. Conclusions: We found no evidence that statin use among people with depression increases mortality or other adverse events. Clinical implications: Our findings support the safety of updated NICE guidelines for prescribing statins in people with depressive disorders

Balneotherapy for osteoarthritis: a systematic review

: This systematic review is aimed to evaluate the effects of balneotherapy with thermal mineral water for managing the symptoms and signs of osteoarthritis located at any anatomical site. The systematic review was conducted according to the PRISMA Statement. The following databases were consulted: PubMed, Scopus, Web of Science, Cochrane Library, DOAJ and PEDro. We included clinical trials evaluating the effects of balneotherapy as a treatment for patients with osteoarthritis, published in English and Italian language, led on human subjects. The protocol was registered in PROSPERO. Overall, 17 studies have been included in the review. All of these studies were performed on adults or elderly patients suffering from osteoarthritis localized to knees, hips, hands or lumbar spine. The treatment assessed was always the balneotherapy with thermal mineral water. The outcomes evaluated were pain, palpation/pressure sensibility, articular tenderness, functional ability, quality of life, mobility, deambulation, ability to climb stairs, medical objective and patients' subjective evaluation, superoxide dismutase enzyme activity, serum levels of interleukin-2 receptors. The results of all the included studies agree and demonstrated an improvement of all the symptoms and signs investigated. In particular, pain and quality of life were the main symptoms evaluated and both improved after the treatment with thermal water in all the studies included in the review. These effects can be attributed to physical and chemical-physical properties of thermal mineral water used. However, the quality of many studies resulted not so high due and, consequently, it is necessary to perform new clinical trial in this field using more correct methods for conducting the study and for processing statistical data